Plant-based Vaccines Market - Size, Share, Outlook, and Opportunity Analysis, 2018 – 2026

Plant-based Vaccines Market - Size, Share, Outlook, and Opportunity Analysis, 2018 – 2026

Report Description

Plants are a cost-effective, safe, and efficacious platform for large-scale production of vaccine in emerging economies and have the potential via oral administration to elicit a mucosal immune response. Key players in the market are focused on Research & Development (R&D) activities for development of plant-based vaccines for the treatment of infectious diseases. This is owing to the ability of plant-based vaccines to be mass produced, with higher efficiency, while maintaining lower cost compared to conventional vaccines.

Furthermore, increasing prevalence of infectious diseases is expected to drive growth of the plant-based vaccines market. For instance, according to World Health Organization (WHO) December 2017 estimate, a seasonal influenza may result in 290,000- 650,000 deaths each year owing to respiratory diseases alone.

Plants as a vaccine source have the ability to generate complex recombinant proteins with desired structures, while maintaining biological functions and offering greater immune-specificity. Plants can be used as potential delivery system for oral vaccines. These factors propel demand for plant-based vaccines. Moreover, successful completion of ongoing clinical trials studies in the future, is expected to offer lucrative opportunity to manufacturers thus, driving growth of the plant-based vaccines market. For instance, according to clinicalTrials: September 2015 update, clinical study evaluating a safety, tolerability and immunogenicity of a plant-made seasonal Quadrivalent VLP influenza vaccine in adults is currently in phase II clinical stage.

Market Dynamics

Higher efficiency of plant-based vaccines over conventional vaccines and R&D activities and clinical trials for the development plant-based are some of the factors expected to boost growth of the market. Plant-based vaccines against HIV have gained significant traction of researchers, since AIDS has evolved as an alarming health problem, which is increasing economic burden of African countries and several emerging economies. According to the The Joint United Nations Programme on HIV/AIDS (UNAIDS); in 2017, Eastern Europe, Central Asia, the Middle East and North Africa accounted for 95% of new HIV infections. Easy production, oral administration of plant-based vaccines, and absence of purification needs offer great advantage in designing plant-based viral vaccines.

Oral vaccines using plant-based formulations are considered as an alternative or may supplement for standard injection vaccines in the Hepatitis B (HBV) treatment, owing to low-cost production and easy vaccination. However, low efficiency and oral-tolerance are the main barrier in the production of plant-based anti-HBV vaccines. Moreover, according to a report published in the International Journal of Molecular Sciences, January 2013, in order to increase the efficiency of HBV antigen expression, intravenous injection of vaccine is required, as plant-produced purified HBV antigens are highly immunogenic when injected.
Key features of the study:
This report provides in-depth analysis of the global plant-based vaccines market, its market size (US$ Million) and Compound Annual Growth Rate (CAGR %) for the forecast period (2020 – 2026), considering 2021, as the base year.
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launch or approval, ongoing research and development activities, regional outlook, and competitive strategy adopted by key players
It profiles key players in the global plant-based vaccines market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
Key companies covered as a part of this study include, Medicago, Inc., iBio, Inc., and Icon Genetics- GmbH.
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future type up-gradation, market expansion, and marketing tactics.
The global plant-based vaccines market report caters to various stakeholders in this industry including investors, researchers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the global plant-based vaccines market.
Detailed Segmentation:
Global Plant-based Vaccines Market, By Vaccine Type:
Bacterial Vaccines
Viral Vaccines
Parasite Vaccines
Others Vaccines
Global Plant-based Vaccines Market, By Source:
Tobacco Plant
Maize
Potato
Others Sources
Global Plant-based Vaccines Market, By Application:
Influenza
Zika Virus Disease
Ebola Virus Disease
Poultry Diseases
Others Applications
Global Plant-based Vaccines Market, By Geography:
U.S.
By Vaccine Type:
Bacterial Vaccines
Viral Vaccines
Parasite Vaccines
Others Vaccines
By Source:
Tobacco Plant
Maize
Potato
Others Sources
By Application:
Influenza
Zika Virus Disease
Ebola Virus Disease
Poultry Diseases
Others Applications
Canada
By Vaccine Type:
Bacterial Vaccines
Viral Vaccines
Parasite Vaccines
Others Vaccines
By Source:
Tobacco Plant
Maize
Potato
Others Sources
By Application:
Influenza
Zika Virus Disease
Ebola Virus Disease
Poultry Diseases
Others Applications
Europe
By Vaccine Type:
Bacterial Vaccines
Viral Vaccines
Parasite Vaccines
Others Vaccines
By Source:
Tobacco Plant
Maize
Potato
Others Sources
By Application:
Influenza
Zika Virus Disease
Ebola Virus Disease
Poultry Diseases
Others Applications
Latin America
Regional Trends
Asia Pacific
Regional Trends
Middle East
Regional Trends
Africa
Regional Trends
Company Profiles
Medicago, Inc.
Company Overview
Product Portfolio
Financial Performance
Recent Developments
Key Strategies
iBio, Inc.
Icon Genetics- GmbH
“*” marked represents similar segmentation in other categories in the respective section.